← SynDRA
BUPRANOLOL
SynDRA canonical compound SYN0002891 — structure-anchored drug synonym record
| Clinical phase | Launched |
|---|
| Primary target(s) | ADRB1 | ADRB2 | ADRB3 |
|---|
| Mechanism of action | adrenergic receptor antagonist |
|---|
| Indication | glaucoma | hypertension |
|---|
| Disease area | cardiology | ophthalmology |
|---|
All known targets
Mechanisms of action (all sources)
- ADRB1 ANTAGONIST
- ADRB2 ANTAGONIST
- ADRB3 ANTAGONIST
- adrenergic receptor antagonist
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
Screening evidence (raw PubChem HTS — uncurated, known false-positive rate)
Drug classes
- Adrenergic Agents
- Adrenergic Antagonists
- Adrenergic beta-Antagonists
- Anti-Arrhythmia Agents
- Antihypertensive Agents
- Cardiovascular Agents
- Neurotransmitter Agents
ATC classes
- C07A · BETA BLOCKING AGENTS
Cross-references
Synonyms
- (+/-)-Bupranolol
- bupranol
- bupranolol hydrochloride
- bupranolol HCl
- Ophtorenin
- B-1312 FREE BASE
- KL-255 FREE BASE
- Bupranol
- Bupranololum
- KL-255
- BRN 2272923
- DTXCID202704
- KL-255 (AS HYDROCHLORIDE)
- KL-255 [AS HYDROCHLORIDE]
- bupranololo
- (+-)-Bupranolol
- RefChem:570502
- C07AA19
- KL255
- 1-(tert-butylamino)-3-(2-chloro-5-methylphenoxy)propan-2-ol
- S-Bupranolol
- 1-(tert-Butylamino)-3-((6-chloro-m-tolyl)-oxy)-2-propanol
- SK&F 16805-A
- 3-(tert-Butylamino)-1-(6-chloro-m-tolyloxy)-2-propanol
- 2-Propanol, 1-(tert-butylamino)-3-(6-chloro-m-tolyloxy)-
- Bupranolol (INN)
- BUPRANOLOL [INN]
- (S)-Bupranolol
- Bupranolol [INN:DCF]
- Bupranololum [INN-Latin]
- (+/-)-Bupranolol; Bupranol; Ophtorenin
- UNII-858YGI5PIT
- 1-(tert-Butylamino)-3-[(6-chloro-m-tolyl)-oxy]-2-propanol
- Bupranolol (Standard)
- BUPRANOLOL [MI]
- BUPRANOLOL [WHO-DD]
- SCHEMBL34061
- GTPL550
Look up BUPRANOLOL in the interactive SynDRA portal →